Hope on the Horizon: Chronic Lymphocytic Leukemia

Mayur Narkhede, MD

Living with chronic lymphocytic leukemia (CLL) can be a challenging journey for both patients and caregivers.  

However, there is a beacon of hope. Tune in to our latest episode, where we speak to Dr. Mayur Narkhede of the University of Alabama about groundbreaking research and innovative treatments for CLL. Discover the potential of CAR T-cell therapy, bispecific antibodies and other cutting-edge options that bring the promise of new hope and possibilities for those affected by CLL. Don’t miss this inspiring and informative discussion! 

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Genentech, Inc.

5 Comments

  1. This information was very informative. I was diagnosed with CLL in 2018. I was asymptomatic and was being monitored. My WBC went as high as 63.5 and I developed large lymph nodes in my groin and under my arm pit. In February 2024 my doctor started treatment with a medication called Calquence and within one month the lymph nodes disappeared and my WBC gradually went down and now it is within normal limits of 6.3. All my blood test are within normal limits, I am hoping that this medication will cure me. I have an excellent doctor and he is very patient and caring.

    1. I also take Calquence. I didn’t have any side effects which makes me very happy. When I first got CLL back in 2015 there weren’t any pills and I had to go on Chemo. It was terrible and I was hospitalized for 3 weeks. I couldn’t go home until my white blood count was up to 5.In 2020 my CLL returned. I thank God every day for Calquence and my doctor for prescribing it.

  2. Great episode, it provides me with a lot of confidence. I now consider myself being in the “time capsule” as Dr. Narkhede calls it. I am waiting for the new treatment for CLL that suits me.

Leave a Comment

Your email address will not be published. Required fields are marked *